MOUSE SERUM Serum Products |
|
GWB-Q00006 |
GenWay Biotech |
100 ml |
Ask for price |
Horse Serum Laboratories manufactures the horse serum cyclosporin reagents distributed by Genprice. The Horse Serum Cyclosporin reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Horse Serum. Other Horse products are available in stock. Specificity: Horse Category: Serum Group: Cyclosporin
Serum albumin |
|
SAB |
1mg |
EUR 2640 |
|
|
Serum albumin |
|
SAB |
1mg |
EUR 2640 |
|
|
Goat serum |
|
Abbexa |
10 nmol |
EUR 287.5 |
Goat serum |
|
Abbexa |
5 nmol |
EUR 237.5 |
Alpaca Serum |
|
Abbexa |
10 nmol |
EUR 1462.5 |
Alpaca Serum |
|
Abbexa |
5 nmol |
EUR 462.5 |
Bovine Serum |
|
Abbexa |
10 nmol |
EUR 287.5 |
Cyclosporin information
Cyclosporin D |
|
MBS130828-100mg |
MyBiosource |
100mg |
EUR 1065 |
Cyclosporin D |
|
MBS130828-500mg |
MyBiosource |
500mg |
EUR 2775 |
Cyclosporin H |
|
MBS130829-100mg |
MyBiosource |
100mg |
EUR 1065 |
Cyclosporin H |
|
MBS130829-500mg |
MyBiosource |
500mg |
EUR 2775 |
Cyclosporin H |
|
MBS130037-100mg |
MyBiosource |
100mg |
EUR 1065 |
Cyclosporin H |
|
MBS130037-500mg |
MyBiosource |
500mg |
EUR 2775 |
Cyclosporin G |
|
MBS131760-100mg |
MyBiosource |
100mg |
EUR 1065 |
Cyclosporin G |
|
MBS131760-500mg |
MyBiosource |
500mg |
EUR 2925 |
Cyclosporin C |
|
MBS131709-100mg |
MyBiosource |
100mg |
EUR 1065 |
Cyclosporin C |
|
MBS131709-500mg |
MyBiosource |
500mg |
EUR 2925 |
Cyclosporin B |
|
MBS131710-100mg |
MyBiosource |
100mg |
EUR 1065 |
Cyclosporin B |
|
MBS131710-500mg |
MyBiosource |
500mg |
EUR 2925 |
Cyclosporin A |
|
HY-B0579 |
MedChemExpress |
10mM/1mL |
EUR 129.87 |
|
Description: Cyclosporin A (Cyclosporine A) is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of protein phosphatase 2B (PP2B/calcineurin) with an IC50 of 5 nM[3]. Cyclosporin A also inhibits CD11a/CD18 adhesion[8]. |
